Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2004 3
2005 2
2006 4
2007 5
2008 4
2009 2
2010 1
2011 1
2012 1
2013 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Antifungal susceptibilities of Cryptococcus neoformans.
Archibald LK, Tuohy MJ, Wilson DA, Nwanyanwu O, Kazembe PN, Tansuphasawadikul S, Eampokalap B, Chaovavanich A, Reller LB, Jarvis WR, Hall GS, Procop GW. Archibald LK, et al. Among authors: chaovavanich a. Emerg Infect Dis. 2004 Jan;10(1):143-5. doi: 10.3201/eid1001.020779. Emerg Infect Dis. 2004. PMID: 15078612 Free PMC article.
Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir.
Manosuthi W, Sungkanuparph S, Ruxrungtham K, Prasithsirikul W, Athichathanabadi C, Tantisiriwat W, Bowonwatanuwong C, Chumpathat N, Chaovavanich A. Manosuthi W, et al. Among authors: chaovavanich a. J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):127-9. doi: 10.1097/QAI.0b013e318157b0da. J Acquir Immune Defic Syndr. 2008. PMID: 18156994 No abstract available.
Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study.
Manosuthi W, Sungkanuparph S, Tansuphaswadikul S, Prasithsirikul W, Athichathanabadi C, Likanonsakul S, Chaovavanich A. Manosuthi W, et al. Among authors: chaovavanich a. Curr Ther Res Clin Exp. 2008 Feb;69(1):90-100. doi: 10.1016/j.curtheres.2008.02.007. Curr Ther Res Clin Exp. 2008. PMID: 24692786 Free PMC article.
Sexually transmitted infection services as a component of HIV care: findings of a demonstration project among HIV-infected women in Thailand.
Sirivongrangson P, Bollen LJ, Chaovavanich A, Suksripanich O, Jirarojwat N, Virapat P, Charoenwatanachokchai A, Lokpichat S, Pobkeeree V, Chantharojwong N, Supawitkul S, Tappero JW, Levine WC. Sirivongrangson P, et al. Among authors: chaovavanich a. J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):671-4. doi: 10.1097/01.qai.0000194233.92959.be. J Acquir Immune Defic Syndr. 2006. PMID: 16652043
Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting.
Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, Sittibusaya C, Moolasart V, Termvises P, Sungkanuparph S. Manosuthi W, et al. Among authors: chaovavanich a. J Infect. 2007 Nov;55(5):464-9. doi: 10.1016/j.jinf.2007.07.002. Epub 2007 Aug 22. J Infect. 2007. PMID: 17714788
25 results